Abstract:Background: In patients with Metabolic associated fatty liver disease (MAFLD), hepatic steatosis is an independent predictor for insulin resistance and cardiovascular risk and hence mortality. Urine biomarker is less complex and has a relatively lower dynamic range with less technical challenges compared to blood. However, little was known whether the urine sample could reflect the altered metabolic/lipid feature in liver and the severity of hepatic steatosis. Therefore, the aim of present study was to investigate the urine molecular pattern and to verify new urine biomarker for hepatic steatosis in MAFLD patients. Method: Hepatic steatosis was measured by Magnetic resonance imaging (MRI) that measure the proton density fat fraction (MRI-PDFF). Mild hepatic steatosis defined as MRI-PDFF 5-10% and the severe hepatic steatosis was defined as MRI-PDFF>10%. Urine samples of 7 healthy controls, 8 MAFLD patients with mild hepatic steatosis, and 12 MAFLD patient with severe steatosis were collected. Proteomic measurements of urine samples were done by mass spectrometry. Western blot and Elisa were performed for validation of potential urine biomarker. Results: There were 53 proteins identified with significantly different expressions among the healthy control, mild steatosis and severe steatosis in MAFLD patients by proteomic data. GO and KEGG analysis of these significantly changed urinary molecular features implied that the MAFLD could result in the dysregulation of carbohydrate derivative catabolic process, glycosaminoglycan process, aminoglycan metabolic process, catabolic process, inflammatory response, insulin-like growth factor receptor, GTPase complex, PI3K−Akt signaling pathway and cholesterol metabolism. Nextly, Alpha-1-acid glycoprotein 1 (ORM1) and ceruloplasmin were the most correlated with clinical parameters in MAFLD, including liver fat content, fibrosis, ALT, triglyceride, glucose, HOMA-IR, and C-reactive protein. Finally, the validation of urine sample (30 cases) by Elisa showed that both ceruloplasmin (healthy control 3.02 ± 1.43 vs. mild steatosis 4.27 ± 1.18 vs. severe steatosis 5.61 ± 1.31, p<0.001) and ORM1 (1.19 ± 1.085 vs. 3.41 ± 2.61 vs. 4.68 ± 3.154, p=0.011) showed an increased tendency from healthy control to mild steatosis and severe steatosis, those results were further validated by western blot. Conclusion: Proteomics profiling allowed us to reveal molecular patterns accompanying hepatic steatosis in MAFLD. Urine ORM1 and ceruloplasmin are potential biomarkers for population-based screening, diagnosing and follow-up for mild/severe hepatic steatosis. Funding Information: This study was supported by the Post-Doctor Research Project of West China Hospital of Sichuan University (grant numbers 2020HXBH079) and National Natural Science Foundation of China (grant numbers 81900512). Declaration of Interests: The authors declare that there are no competing interests associated with the manuscript. Ethics Approval Statement: The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki. The Institutional Review Board Committee of West China Hospital of Sichuan university approved the study protocol. The study was performed by following the ethical guidelines expressed in the Declaration of Helsinki and the International Conference on Harmonization Guidelines for Good Clinical Practice. Informed consent was obtained from all subjects.

Urine Metabolomics of High-Fat Diet Induced Obesity Using UHPLC-Q-TOF-MS.

Systemic Perturbations Of Key Metabolites In Diabetic Rats During The Evolution Of Diabetes Studied By Urine Metabonomics

Metabolomic Profilings of Urine and Serum from High Fat-Fed Rats Via 1H NMR Spectroscopy and Pattern Recognition

Metabolic profilings of urine from high fat-fed rats based on 1 H NMR metabolomics

High-fat diet induces dynamic metabolic alterations in multiple biological matrices of rats.

Correlations of Fecal Metabonomic and Microbiomic Changes Induced by High-Fat Diet in the Pre-Obesity State

Transcriptomic and Metabonomic Profiling of Obesity-Prone and Obesity-Resistant Rats under High Fat Diet.

Altered adolescents obesity metabolism is associated with hypertension: a UPLC-MS-based untargeted metabolomics study

Profound perturbation in the metabolome of a canine obesity and metabolic disorder model

Urinary metabonomics study in a rat model in response to protein-energy malnutrition by using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.

An integrating strategy for serum metabolomics and microarray analysis to expand the understanding of diet-induced obesity

Effect of Metformin on the Urinary Metabolites of Diet-Induced-obese Mice Studied by Ultra Performance Liquid Chromatography Coupled to Time-of-flight Mass Spectrometry (UPLC-TOF/MS).

Alterations of Bile Acids and Gut Microbiota in Obesity Induced by High Fat Diet in Rat Model.

Dose-Related Urinary Metabolic Alterations of a Combination of Quercetin and Resveratrol-Treated High-Fat Diet Fed Rats.

Metabonomic profiling of diet-induced hyperlipidaemia in a rat model.

Integrated omics analysis reveals the alteration of gut microbe-metabolites in obese adults

Urine Proteome in Patients With Metabolic Associated Fatty Liver Disease

Investigation of pH-dependent 1 H NMR urine metabolite profiles for diagnosis of obesity-related disordering

Proteomic Analysis of Rat Hypothalamus Revealed the Role of Ubiquitin–Proteasome System in the Genesis of DR or DIO

Serum Metabolomics Analysis for Biomarkers of Lactobacillus plantarum FRT4 in High-Fat Diet-Induced Obese Mice

A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat Diet